Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy

BACKGROUND: The goal of this study was to identify potential predictive biomarkers for the therapeutic effect of infliximab (IFX) in Rheumatoid arthritis (RA) and explore the potential molecular mechanism of nonresponse to IFX treatment to achieve individualized treatment of RA. METHODS: Differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yongsong, Xu, Ke, Aihaiti, Yirixiati, Li, Zhijin, Yuan, Qiling, Xu, Jing, Zheng, Haishi, Yang, Mingyi, Wang, Bo, Yang, Yanni, Yang, Yin, Xu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762214/
https://www.ncbi.nlm.nih.gov/pubmed/35046954
http://dx.doi.org/10.3389/fimmu.2021.795912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762214/
https://www.ncbi.nlm.nih.gov/pubmed/35046954
http://dx.doi.org/10.3389/fimmu.2021.795912

Ejemplares similares